本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Supernus Pharmaceuticals

32.34
-1.2500-3.72%
盘后32.340.00000.00%16:34 EDT
成交量:69.05万
成交额:2,258.18万
市值:18.11亿
市盈率:29.22
高:33.83
开:33.83
低:32.20
收:33.59
数据加载中...
2024/04/08

重要事件披露

Form 8-K - Current report
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K - Current report
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]